Corporate News     03-Jul-23
ERIS Lifesciences acquires dermatology brands from subsidiary
For consideration of Rs 339.68 cr
ERIS Lifesciences announced that its wholly owned subsidiary, Eris Oaknet Healthcare has transferred to the Company all the dermatology trademarks that had been previously acquired from Glenmark Pharmaceuticals and reported vide our disclosure dated 17 January 2023. The consideration for this intra group transfer is ~Rs.339.68 crore.
Previous News
  ERIS Lifesciences to convene AGM
 ( Corporate News - 05-Aug-24   18:42 )
  ERIS Lifesciences consolidated net profit declines 12.31% in the June 2024 quarter
 ( Results - Announcements 02-Aug-24   15:14 )
  ERIS Lifesciences announces board meeting date
 ( Corporate News - 31-Jul-24   12:40 )
  Eris Lifesciences allots 22,492 equity shares under ESOP
 ( Corporate News - 24-Jun-24   12:26 )
  Board of ERIS Lifesciences approves composite scheme of arrangement
 ( Corporate News - 21-May-24   18:42 )
  Board of ERIS Lifesciences approves NCD issuance up to Rs 1250 cr
 ( Corporate News - 21-May-24   18:40 )
  ERIS Lifesciences consolidated net profit rises 8.47% in the March 2024 quarter
 ( Results - Announcements 21-May-24   17:48 )
  ERIS Lifesciences standalone net profit declines 55.02% in the March 2024 quarter
 ( Results - Announcements 21-May-24   17:47 )
  ERIS Lifesciences to table results
 ( Corporate News - 15-May-24   15:28 )
  Board of Eris Lifesciences approves acquisition of branded formulations biz of Biocon Biologics
 ( Corporate News - 14-Mar-24   18:54 )
  ERIS Lifesciences consolidated net profit rises 0.86% in the December 2023 quarter
 ( Results - Announcements 14-Feb-24   14:33 )
Other Stories
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
  Reliance Industrial InfraStructure declare Quarterly Result
  05-Oct-24   10:11
Back Top